Post-market lot-to-lot evaluation of the VivaDiag serological assay for COVID-19
This report contains the results of the post-market lot-to-lot evaluation of the VivaDiag serological assay for the detection of SARS-CoV-2.
Downloads
Post-market lot-to-lot evaluation of the VivaDiag serological assay for COVID-19
We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
Publication date:
15 April 2021
Publication type:
Report
Intended audience:
Health sector
Part of a collection: